Latest Press Releases
View all
TimeHeadline
27m agoEducational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
28m agoAgibank Closes Second FIDC Structuring, Raises R$2.5 Billion
28m agoNew Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation
28m agoROYAL CARIBBEAN GROUP CONFIRMS ORDER WITH MEYER TURKU FOR ICON 6 AND 7
1h agoFirst Stoping Operations at Perseus Mining's CMA Underground
Nexalis Therapeutics Limited logo

Nexalis Therapeutics Limited

About

Nexalis Therapeutics Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 19 2026
First patient dosed in IRX-616a Phase 1 trial
Mar 4 2026
First eligible participant screened - phase 1 IRX-616a study
Feb 27 2026
Preliminary Final Report
Jan 29 2026
Dec25 Quarterly Activities Report
Jan 29 2026
Dec25 Appendix 4C Cash Flow Report

Community Chat

Ask AI

6ix6ixAIEvents